Psilocybin for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Why this status

  1. 1 Sep 2020: Trial started, NCT04593563
  2. 20 Oct 2020: Trial registered, NCT04593563
  3. 17 Jul 2023: Trial registered, NCT05947383
  4. 23 Oct 2023: Trial started, NCT05947383
  5. 20 Mar 2024: Trial registered, NCT06319378
  6. 19 Apr 2024: Trial started, NCT06319378
  7. 30 Jan 2025: Trial registered, NCT06801041
  8. 23 May 2025: Trial started, NCT06801041

The trials

NCT00465595: Psychopharmacology of Psilocybin in Cancer Patients

State
Completed
Phase
Phase 2
People
56 taking part
Started
Apr 2007
Primary completion
Dec 2014
Arms
Low Dose First, High Dose Second, High Dose First, Low Dose Second
Results
Posted on the registry
  1. 25 Apr 2007: Trial registered
  2. 19 Jul 2018: Trial results posted

NCT04593563: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

State
State not given
Phase
Phase 2
People
30 taking part
Started
1 Sep 2020
Primary completion
Oct 2022
Arms
Psilocybin 25mg
Results
None posted
  1. 1 Sep 2020: Trial started
  2. 20 Oct 2020: Trial registered

NCT05947383: Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

State
Under way
Phase
Phase 2
People
56 planned
Started
23 Oct 2023
Primary completion
30 Apr 2027
Arms
Psilocybin
Results
None posted
  1. 17 Jul 2023: Trial registered
  2. 23 Oct 2023: Trial started

NCT06319378: Cancer Related Major Depression Treated With a Single Dose of Psilocybin

State
Under way
Phase
Phase 2
People
100 planned
Started
19 Apr 2024
Primary completion
Dec 2026
Arms
psilocybin 25 mg (active)
Results
None posted
  1. 20 Mar 2024: Trial registered
  2. 19 Apr 2024: Trial started

NCT06801041: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

State
Under way
Phase
Phase 2
People
20 planned
Started
23 May 2025
Primary completion
31 Mar 2027
Arms
Treatment with Psilocybin
Results
None posted
  1. 30 Jan 2025: Trial registered
  2. 23 May 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as High Dose Psilocybin, Low Dose Psilocybin, Medium Dose Psilocybin, Psilocybin (0.25mg/kg), Psilocybin (Usona Institute), Psilocybin (drug), Psilocybin 100 mcg/kg, Psilocybin 25 mg, Psilocybin 25 mg per os, Psilocybin 25mg, Psilocybin assisted therapy, Psilocybin first, Psilocybin plus Visual Healing Set and Setting, Psilocybin therapy, psilocybin 25 mg sod.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.